Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Abercrombie & Fitch Company (ANF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Abercrombie & Fitch Company (ANF) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for March 13th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 13th:
Abercrombie & Fitch Co. (ANF - Free Report) : This specialty retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.
Abercrombie & Fitch Company Price and Consensus
Abercrombie & Fitch Company price-consensus-chart | Abercrombie & Fitch Company Quote
Abercrombie & Fitch’s shares gained 43.8% over the past three months compared with the S&P 500’s advance of 8.1%. The company possesses a Momentum Score of A.
Abercrombie & Fitch Company Price
Abercrombie & Fitch Company price | Abercrombie & Fitch Company Quote
LeMaitre Vascular, Inc. (LMAT - Free Report) : This medical devices and implants company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the last 60 days.
LeMaitre Vascular, Inc. Price and Consensus
LeMaitre Vascular, Inc. price-consensus-chart | LeMaitre Vascular, Inc. Quote
LeMaitre Vascular’s shares gained 17.8% over the last three months compared with the S&P 500’s advance of 8.1%. The company possesses a Momentum Score of B.
LeMaitre Vascular, Inc. Price
LeMaitre Vascular, Inc. price | LeMaitre Vascular, Inc. Quote
CRH plc (CRH - Free Report) : This manufacturer of building materials has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.
CRH PLC Price and Consensus
CRH PLC price-consensus-chart | CRH PLC Quote
CRH’s shares gained 24.7% over the last three months compared with the S&P 500’s advance of 8.1%. The company possesses a Momentum Score of A.
CRH PLC Price
CRH PLC price | CRH PLC Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.